# Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers

> **NCT04692025** · PHASE1 · COMPLETED · sponsor: **Gannex Pharma Co., Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Healthy
- NAFLD
- Hyperlipidemia

## Interventions

- **DRUG:** ASC41 tablet

## Key facts

- **NCT ID:** NCT04692025
- **Lead sponsor:** Gannex Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-27
- **Primary completion:** 2021-01-14
- **Final completion:** 2021-01-21
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04692025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04692025, "Study to Evaluate the Effect of Food on the Pharmacokinetics of ASC41 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04692025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*